P179 - Positive HER3 could be a marker of poor response to neoadjuvant dual anti-HER2 therapy in breast cancer
| Autor: | Ramić, S., Perić Balja, M., Veliki Dalić, I., Milković Periša, M., Orešic, T., Milas, I. |
|---|---|
| Zdroj: | In The Breast March 2019 44 Supplement 1:S77-S77 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect